CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 186 filers reported holding CHEMOCENTRYX INC in Q1 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $38,711,000 | +5344.6% | 749,342 | +2542.6% | 0.18% | +8900.0% |
| Q1 2022 | $711,000 | -81.7% | 28,356 | -62.5% | 0.00% | -88.2% |
| Q1 2021 | $3,878,000 | -42.1% | 75,677 | -30.0% | 0.02% | -41.4% |
| Q4 2020 | $6,698,000 | +24.5% | 108,167 | +10.2% | 0.03% | +38.1% |
| Q3 2020 | $5,378,000 | +3.7% | 98,131 | +8.9% | 0.02% | -19.2% |
| Q2 2020 | $5,185,000 | +304.4% | 90,111 | +182.6% | 0.03% | +225.0% |
| Q1 2020 | $1,282,000 | +161.1% | 31,887 | -56.0% | 0.01% | +300.0% |
| Q3 2019 | $491,000 | -56.6% | 72,465 | -40.5% | 0.00% | -50.0% |
| Q2 2019 | $1,132,000 | +8.7% | 121,760 | +62.4% | 0.00% | 0.0% |
| Q1 2019 | $1,041,000 | +308.2% | 74,961 | +270.4% | 0.00% | +300.0% |
| Q3 2018 | $255,000 | – | 20,239 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |